76. Histrelin Implants for Puberty Suppression in Transgender Children and Adolescents
Transgender children and adolescents may present to care for puberty suppression to prevent undesired and potentially irreversible phenotypic changes that are incongruent with their gender identity. Though histrelin implants have been approved and studied for hormonal axis suppression in medical conditions such as prostate cancer and central precocious puberty, limited data describe its use among children and adolescents with gender dysphoria. Our study aims to characterize the use of the histrelin implant for puberty suppression among transgender youth.
Source: Journal of Pediatric and Adolescent Gynecology - Category: OBGYN Authors: Rula Kanj, Whitney Wellenstein, Danielle Cipres Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Hormones | OBGYN | Pediatrics | Prostate Cancer | Study